(Q37298870)

19 August 2017

1 reference

title

Rotavirus vaccines: viral shedding and risk of transmission (English)

1 reference

19 August 2017

1 reference

Evan J Anderson

1

1 reference

19 August 2017

1 October 2008

1 reference

Lancet Infectious Diseases

19 August 2017

1 reference

19 August 2017

8

1 reference

19 August 2017

642-649

1 reference

19 August 2017

10

1 reference

Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003.

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Rotavirus vaccines: current prospects and future challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Cost-effectiveness analysis of a rotavirus immunization program for the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Intussusception among infants given an oral rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Rotavirus infection in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Transmission of rotavirus and other enteric pathogens in the home

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Rotavirus enteritis in solid organ transplant recipients: an underestimated problem?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Tetravalent rhesus rotavirus vaccine in young infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety and immunogenicity of tetravalent rhesus-based rotavirus vaccine in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Shedding of rotavirus after administration of the tetravalent rhesus rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Evaluation of a reassortant rhesus rotavirus vaccine in young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Simultaneous Administration of Two Human-Rhesus Rotavirus Reassortant Strains of VP7 Serotype 1 and 2 Specificity to Infants and Young Children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Field trial of rhesus rotavirus vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Prolonged efficacy of rhesus rotavirus vaccine in Swedish children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety, Immunogenicity, and Protective Efficacy of One and Three Doses of the Tetravalent Rhesus Rotavirus Vaccine in Infants in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Horizontal transmission of rhesus monkey rotavirus-based quadrivalent vaccine during a phase 3 clinical trial in Caracas, Venezuela.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Lack of shedding of the RIX4414 live attenuated rotavirus vaccine administered to adult volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Reactogenicity and immunogenicity of rotavirus WC3 vaccine in 5-12 month old infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the Rotavirus Efficacy and Safety Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

Prevention of rotavirus disease: guidelines for use of rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

New rotavirus vaccines: renewed optimism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970231-7

7 January 2021

10.1016/S1473-3099(08)70231-7

Identifiers

DOI

1 reference

release_keeglbtfmzd2bgb2trgxgcttoe

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/keeglbtfmzd2bgb2trgxgcttoe

24 November 2022

mapped directly with Wikidata item

PubMed ID

18922486

1 reference

PubMed ID

18922486